Migraine and obesity: Epidemiology, mechanisms, and implications

Headache

Volumn 50, Issue 4, 2010, Pages 631-648

  Peterlin, B Lee ^a   Rapoport, Alan M ^b,c   Kurth, Tobias ^d,e,f  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NEW ENGLAND CENTER FOR HEADACHE   (United States)

^d INSERM   (France)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Abdominal obesity; Adipocytokines; Adiponectin; BMI; Migraine; Obesity

Indexed keywords

ACT 078573; ADIPOCYTOKINE; ADIPONECTIN; ANTIMIGRAINE AGENT; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; LEPTIN; OREXIN; SB 649868; SEROTONIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ABDOMINAL OBESITY; AGE DISTRIBUTION; BODY FAT DISTRIBUTION; BODY MASS; CLIMACTERIUM; DIETARY INTAKE; DISEASE ASSOCIATION; DRUG MECHANISM; ENERGY BALANCE; FEEDING BEHAVIOR; HEADACHE; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MIGRAINE; NONHUMAN; PATHOPHYSIOLOGY; POSTMENOPAUSE; PREVALENCE; PRIORITY JOURNAL; REPRODUCTION; REVIEW; SLEEP DISORDER;

ABDOMINAL FAT; ADIPOCYTES; ADIPOKINES; ADIPOSE TISSUE; COMORBIDITY; FEEDING BEHAVIOR; FEMALE; HUMANS; INFLAMMATION; MALE; MIGRAINE DISORDERS; OBESITY; PEPTIDES; SIGNAL TRANSDUCTION;

EID: 77950526065     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2009.01554.x     Document Type: Review

References (75)

1. Gelber RP, Gaziano JM, Orav EJ, Manson JE, Buring JE, Kurth T. Measures of obesity and cardiovascular risk among men and women. J Am Coll Cardiol. 2008 52 : 605 615.
2. Li C, Ford ES, McGuire LC, Mokdad AH. Increasing trends in waist circumference and abdominal obesity among U.S. adults. Obesity. 2007 15 : 216 224.
3. Kurth T, Gaziano JM, Rexrode KM, et al. Prospective study of body mass index and risk of stroke in apparently healthy women. Circulation. 2005 111 : 1992 1998.
4. Yusuf S, Hawken S, Ounpuu S, et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: A case-control study. Lancet. 2005 366 : 1640 1649.
5. Wang Y, Rimm EB, Stampfer MJ, et al. Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am J Clin Nutr. 2005 81 : 555 563.
6. Onat A, Avci GS, Barlan MM, Uyarel H, Uzunlar B, Sansoy V. Measures of abdominal obesity assessed for visceral adiposity and relation to coronary risk. Int J Obes. 2004 28 : 1018 1025.
7. Lean ME, Han TS, Seidell JC. Impairment of health and quality of life in people with large waist circumference. Lancet. 1998 351 : 853 856.
8. Scher AI, Stewart WF, Ricci JA, Lipton RB. Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain. 2003 106 : 81 89.
9. Wendelboe AM, Hegmann KT, Biggs JJ, et al. Relationships between body mass indices and surgical replacements of knee and hip joints. Am J Prev Med. 2003 25 : 290 295.
10. Kissebah AH, Krakower GR. Regional adiposity and morbidity. Physiol Rev. 1994 74 : 761 811.
11. Wajchenberg BL, Giannella-Neto D, da Silva ME, Santos RF. Depot-specific hormonal characteristics of subcutaneous and visceral adipose tissue and their relation to the metabolic syndrome. Horm Metab Res. 2002 34 : 616 621.
12. Dieudonne MN, Leneveu MC, Giudicelli Y, et al. Evidence for functional estrogen receptors alpha and beta in human adipose cells: Regional specificities and regulation by estrogens. Am J Physiol Cell Physiol. 2004 286 : C655 C661
13. Shen W, Punyanitya M, Silva AM, et al. Sexual dimorphism of adipose tissue distribution across the lifespan: A cross-sectional whole-body magnetic resonance imaging study. Nutr Metab. 2009 6 : 17.
14. Peterlin BL, Rosso AL, Rapoport AM, Scher AI. Obesity and migraine: The effect of age, gender and adipose tissue distribution. Headache. 2009 (in press).
15. Boogerd A, Alverdy J, Kumar S, et al. Part II. Obesity. Dis Mon. 2002 48 : 725 742.
16. Prentice AM, Jebb SA. Beyond body mass index. Obes Rev. 2001 2 : 141 147.
17. Heiat A, Vaccarino V, Krumholz HM. An evidence-based assessment of federal guidelines for overweight and obesity as they apply to elderly persons. Arch Intern Med. 2001 161 : 1194 1203.
18. Folsom AR, Kushi LH, Anderson KE, et al. Associations of general and abdominal obesity with multiple health outcomes in older women: The Iowa Women's Health Study. Arch Intern Med. 2000 24 : 2117 2128.
19. Ogden CL, Yanovski SZ, Carroll MD, Flegal KM. The epidemiology of obesity. Gastroenterology. 2007 132 : 2087 2102.
20. Gorber SC, Tremblay M, Moher D, Gorber D. A comparison of direct vs. self-report measures for assessing height, weight and body mass index: A systemic review. Obes Rev. 2007 8 : 307 326.
21. Katsnelson MJ, Peterlin BL, Rosso AL, et al. Self-reported versus measured body mass indices in migraineurs. Headache. 2009 49 : 663 668.
22. Shen W, St-Onge MP, Wang Z, Heymsfield SB. Study of body composition: An overview. In : Heymsfiel SB, Lohman TG, Wang Z, Going SB, eds. Human Body Composition.
23. WHO. Obesity-Preventing and Managing the Global Epidemic. Report of WHO Consultation on Obesity.
24. Lean ME, Han TS, Morrison CE. Waist circumference as a measure for indicating need for weight management. BMJ. 1995 311 : 158 161.
25. Bigal ME, Lipton RB. Obesity is a risk factor for transformed migraine but not chronic tension-type headache. Neurology. 2006 67 : 252 257.
26. Peterlin BL, Alexander G, Tabby D, Reichenberger E. Oligomerization state-dependent elevations of adiponectin in chronic daily headache. Neurology. 2008 70 : 1905 1911.
27. Ashkenazi A, Silberstein SD. Hormone-related headache: Pathophysiology and treatment. CNS Drugs. 2006 20 : 125 141.
28. Peres MFP, Lerario DDG, Garrido AB, Zukerman E. Primary headaches in obese patients. Arq Neuropsiquiatr. 2005 63 : 931 933.
29. Horev A, Wirguin I, Lantsberg L, Ifergane G. A high incidence of migraine with aura among morbidly obese women. Headache. 2005 45 : 936 938.
30. Bigal M, Liberman JN, Lipton RB. Obesity and migraine. Neurology. 2006 66 : 545 550.
31. Keith SW, Wang C, Fontaine KR, et al. BMI and headache among women: Results from 11 epidemiologic datasets. Obesity. 2008 16 : 377 383.
32. Ford ES, Li C, Pearson WS, et al. Body mass index and headaches: Findings from a national sample of US adults. Cephalalgia. 2008 28 : 1270 1276.
33. Mattsson P. Migraine headache and obesity in women aged 40-74 years: A population-based study. Cephalalgia. 2007 27 : 877 880.
34. Winter AC, Berger K, Buring JE, Kurth T. Body mass index, migraine frequency and migraine features in women. Cephalalgia. 2009 29 : 269 278.
35. Schurks M, Buring JE, Kurth T. Agreement of self-reported migraine with ICHD-II criteria in the Women's Health Study. Cephalalgia. 2009 29 : 1086 1090.
36. Tilg H, Moschen AR. Adipocytokines: Mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol. 2006 6 : 772 783.
37. Bray GA. Drug insight: Appetite suppressants. Nat Clin Pract Gastroenterol Hepatol. 2005 2 : 89 95.
38. Coppola A, Diano S. Hormonal regulation of the arcuate nucleus melanocortin system. Front Biosci. 2007 12 : 3519 3530.
39. Crowley VEF, Yeo GSH, O'Rahilly S. Obesity therapy: Alternating the energy intake-and-expenditure balance sheet. Nature. 2002 1 : 276 286.
40. Blau JN. Migraine prodromes separated from the aura: Complete migraine. BMJ. 1980 281 : 658 660.
41. Denuelle M, Fabre N, Payoux P, Chollet F, Geraud G. Hypothalamic activation in spontaneous migraine attacks. Headache. 2007 47 : 1418 1426.
42. Peterlin BL, Rapoport AM. Clinical pharmacology of the serotonin receptor agonist, zolmitriptan. Expert Opin Drug Metab Toxicol. 2007 3 : 899 911.
43. Halford JCG, Harrold JA, Boyland EJ, Lawton CL, Blundell JE. Serotonergic drugs: Effects on appetite expression and use for the treatment of obesity. Drugs. 2007 67 : 27 55.
44. Nonogaki K, Strack AM, Dallman MF, Tecott LH. Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2C receoptor gene. Nat Med. 1998 4 : 1152 1156.
45. Hamele E, Saxena PR. 5-Hydroxytryptamine involvement in migraines. In : Olesen J, Goadsby PJ, Ramadan NM, Tfelt-Hansen P, Welch KMA eds. The Headaches, 3rd edn.
46. Budakov D, Alexopoulus H. Metabolic state signaling through central hypocretin/orexin neurons. J Cell Mol Med. 2005 9 : 795 803.
47. Mobarakeh JI, Takahashi K, Sakurada S, et al. Enhanced antinociception by intracerebroventricularly administered orexin A in histamine H1 or H2 receptor gene knockout mice. Pain. 2005 118 : 254 262.
48. Bingham S, Davey PT, Babbs AJ, et al. Orexin-A, an hypothalamic peptide with analgesic properties. Pain. 2001 92 : 81 90.
49. Heinonen MV, Purhonen AK, Makela KA, Herzig KH. Functions of orexins in peripheral tissues. Acta Physiol. 2008 192 : 471 485.
50. Cheng J, Chou RC, Hwang L, Chiou L. Antiallodynic effects of intrathecal orexins in a rat model of postoperative pain. J Pharmacol Exp Ther. 2003 303 : 1065 1071.
51. Holland PR, Akerman S, Goadsby PJ. Orexin 1 receptor activation attenuates neurogenic dural vasodilation in an animal model of trigeminovascular nociception. J Pharmacol Exp Ther. 2005 315 : 1380 1385.
52. Holland PR, Akerman S, Goadsby PJ. Modulation of nociceptive dural input to the trigeminal nucleus caudalis via activation of the orexin 1 receptor in the rat. Eur J Neurosci. 2006 24 : 2825 2833.
53. Sarchielli P, Rainero I, Coppola F, et al. Involvement of corticotrophin-releasing factor and orexin-A in chronic migraine and medication-overuse headache: Findings form cerebrospinal fluid. Cephalalgia. 2008 28 : 714 722.
54. Cormac S. Actelion, GSK ink $3.2B deal with Almacexant as centerpiece http://www.bioworld.com/servlet/com.accumedia.web.Dispatcher?next= bioWorldHeadlines-article&forceid=48183
55. http://en.wikipedia.org/wiki/Orexin
56. Peterlin BL, Bigl M, Tepper SJ, Urakaze M, Sheftell FD, Rapoport AM. Migraine and adiponectin: Is there a connection? Cephalalgia. 2007 27 : 435 446.
57. Berilgen MS, Bulut S, Gonen M, et al. Comparison of the effects of amitriptyline and flunarizine on weight gain and serum leptin, C peptide and insulin levels when used as migraine preventive treatment. Cephalalgia. 2005 25 : 1048 1053.
58. Guldiken B, Guldiken S, Demir M, Turgut N, Tugrul A. Low leptin levels in migraine: A case control study. Headache. 2008 40 : 1103 1107.
59. Kos K, Harte AL, da Silva NF, et al. Adiponectin and resistin in human cerebrospinal fluid and expression of adiponectin receptors in human hypothalamus. J Clin Endocrinol Metab. 2007 92 : 1139 1136.
60. Tsao TS, Tomas E, Murrey HE, et al. Role of disulfide bonds in acrp30/adiponectin structure and signaling specificity. J Biol Chem. 2003 278 : 50810 50817.
61. Combs TP, Berg AH, Rajala MW, et al. Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein aidponectin. Diabetes. 2003 52 : 268 276.
62. Tsatsanis C, Zacharioudaki V, Androulidaki A, et al. Adiponectin induces TNF-α and IL-6 in macrophages and promotes tolerance to itself and other pro-inflammatory stimuli. Biochem Biophys Res Commun. 2005 335 : 1254 1263.
63. Haugen F, Drevon CA. Activation of nuclear factor-kB by high molecular weight and globular adiponectin. Endocrinology. 2007 148 : 5478 5486.
64. Lago F, Dieguez C, Gomez-Reino J, Gualillo O. The emerging role of adipokines as mediators of inflammation and immune responses. Cytokine Growth Factor Rev. 2007 18 : 313 325. (Pubitemid 46891288)
65. Tena-Sempere M, Manna PR, Zhang FP, et al. Molecular mechanisms of leptin action in adult rat testis: Potential targets for leptin-induced inhibition of steroidogenesis and pattern of leptin receptor messenger ribonucleic acid expression. J Endocrinol. 2001 170 : 413 423.
66. Lin KC, Sagawa N, Yura S, Itoh H, Fujii S. Simulataneous increases of leptin and gondadotropin-releasing hormone following exogenous estrogen administration in women with normally menstrual cycle. Endocr J. 2005 52 : 449 454.
67. Loffreda S, Yang SQ, Lin HZ, et al. Leptin regulates pro-inflammatory immune responses. FASEB J. 1998 12 : 57 65.
68. Tang CH, Lu DY, Yang RS, et al. Leptin-induced IL-6 production is mediated by leptin receptor, insulin receptor substrate-1, phosphatidylinositol 3-kinase, Akt, NF-kb, and p300 pathway in migroglia. Immunology. 2007 179 : 1292 1302.
69. Kutlu S, Canpolat S, Sandal S, Ozcan M, Sarsilmaz M, Kelestimur H. Effects of central and peripheral administration of leptin on pain threshold in rats and mice. Neuro Endocrinol Lett. 2003 24 : 193 196.
70. Otero M, Lago R, Gomez R, et al. Towards a pro-inflammoatory and immunomodulatory emerging role of leptin. Rheumatology. 2006 45 : 944 950.
71. Wang B, Trayhurn P. Acute and prolonged effects of TNF-α on the expression and secretion of inflammation-related adipokines by human adipocytes differentiated in culture. Pflugers Arch. 2006 452 : 418 427.
72. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003 112 : 1796 1808.
73. Sarchielli P, Alberti A, Baldi A, et al. Proinflammatory cytokines, adhesion molecules, and lymphocyte integrin expression in the internal jugular blood of migraine patients without aura assessed ictally. Headache. 2006 46 : 200 207.
74. Rozen T, Swidan SZ. Elevation of CSF tumor necrosis factor alpha levels in new daily persistent headache and treatment refractory chronic migraine. Headache. 2007 47 : 1050 1055.
75. Munno I, Marinaro M, Bassi A, et al. Immunological aspects in migraine: Increase of IL-10 plasma levels during attack. Headache. 2001 41 : 764 767.